Abstract

Pharmaceutical company is a type of company that in its operational activities produces medicinal products for health, unlike trading companies that sell products.This situation will provide an opportunity for investors to invest in the company.The purpose of this study was to determine the effect of Long debt equity ratio and Current ratio on stock returns with stock investment risk as an intervening variable in Pharmaceutical Companies listed on the Indonesia Stock Exchange for the 2017-2020 period.The population in this study were all pharmaceutical companies listed on the Indonesia Stock Exchange for the 2017-2020 period as many as 12 companies.The sampling technique was determined by purposive sampling.Analysis of hypothesis testing data in this study using the Structural Equation-Partial Least Square (PLS-SEM) method.
 Long Debt Equity Ratio has a significant negative effect on stock investment risk.Current Ratio has a negative but not significant effect on stock investment risk,Long Debt Equity Ratio has a negative but not significant effect on stock returns,Current Ratio has a positive but not significant effect on stock returns,Stock investment risk has a significant positive effect on stock returns,The results of the indirect effect hypothesis test show that the Long Debt Equity Ratio has a significant negative effect on stock returns through stock investment risk,Current Ratio has a negative but not significant effect on stock returns through stock investment risk.

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.